Drug for acute treatment of social anxiety disorder did not meet primary endpoint
A nasal spray to treat anxiety did not meet its primary endpoint and was not…
A nasal spray to treat anxiety did not meet its primary endpoint and was not…
Psychedelic drugs have the potential to become an effective treatment for crippling mental health conditions…
In spite of recent failures of clinical trials from others in the field, Swiss company…
Scientists at the University of Cambridge have developed a way to screen treatments for schizophrenia…
The French biotech MedinCell, an injectable slow-release drug specialist, has received a shot of success…
Santa Claus is not the only busy one in the weeks leading up to Christmas…
Cambridge University scientists have identified a chemical in the brain that blocks unwanted thoughts, offering a…
Researchers from Austria and the UK have made new advances in engineering brain-like structures. These…
Biotech entrepreneur Hervé Affagard, CEO of MaaT Pharma, tells the story behind the success of…
The canals of Amsterdam have attracted us this week to the capital of the Netherlands,…
Heptares Therapeutics has acquired G7 Therapeutics to take control over its GPCR technology, boost its…
Biotech is one of the main forces driving the development of effective therapies to treat neurological and…